Anika Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ANIK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

106,297

Value ($000)

1,022

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,022	0.0%	106,297	12/31/2025
2025 Q3	11/10/2025	976	0.0%	103,870	9/30/2025
2025 Q2	8/12/2025	1,408	0.0%	133,047	6/30/2025
2025 Q1	9/15/2025	2,254	0.0%	149,935	3/31/2025
2024 Q4	2/6/2025	2,263	0.0%	137,462	12/31/2024
2024 Q3	11/12/2024	3,704	0.0%	149,956	9/30/2024
2024 Q2	8/12/2024	3,803	0.0%	150,144	6/30/2024
2024 Q1	5/9/2024	3,718	0.0%	146,368	3/31/2024
2023 Q4	2/6/2024	2,677	0.0%	118,157	12/31/2023
2023 Q3	11/8/2023	2,117	0.0%	113,611	9/30/2023
2023 Q2	8/10/2023	2,916	0.0%	112,249	6/30/2023
2023 Q1	5/12/2023	3,174	0.0%	110,499	3/31/2023
2022 Q4	2/13/2023	3,290	0.0%	111,159	12/31/2022
2022 Q3	11/14/2022	2,595	0.0%	109,007	9/30/2022
2022 Q2	8/15/2022	2,323	0.0%	104,072	6/30/2022
2022 Q1	5/13/2022	2,616	0.0%	104,150	3/31/2022
2021 Q4	2/11/2022	3,640	0.0%	101,570	12/31/2021
2021 Q3	11/16/2021	4,323	0.0%	101,565	9/30/2021
2021 Q2	8/16/2021	4,314	0.0%	99,648	6/30/2021
2021 Q1	5/17/2021	4,837	0.0%	118,567	3/31/2021
2020 Q4	2/16/2021	5,140	0.0%	113,551	12/31/2020
2020 Q3	11/13/2020	4,015	0.0%	113,431	9/30/2020
2020 Q2	8/20/2020	4,292	0.0%	113,748	6/30/2020
2020 Q1	5/15/2020	3,341	0.0%	115,538	3/31/2020
2019 Q4	2/7/2020	6,273	0.0%	120,966	12/31/2019
2014 Q2	7/30/2014	4,805	0.0%	103,710	6/30/2014
2014 Q1	4/29/2014	5,879	0.0%	143,030	3/31/2014
2013 Q4	2/14/2014	5,325	0.0%	139,530	12/31/2013